Literature DB >> 15331937

Renal vasculitis: increasingly a disease of the elderly?

S C Satchell1, A J Nicholls, R J D'Souza, M Beaman.   

Abstract

BACKGROUND/AIMS: The majority of patients presenting to our district general hospital with renal vasculitis are elderly. Older patients respond less well to treatment and have a poorer prognosis. We investigated the relationship between age and outcome of renal vasculitis in our centre and examined the evidence regarding treatment of elderly patients with this condition.
METHODS: Patients presenting over a 2-year period with renal vasculitis were identified by clinical and histological features and by antineutrophil cytoplasmic autoantibody positivity. They were followed for a mean of 15 months and outcomes were recorded. Results were compared with published studies.
RESULTS: The mean age at presentation of 21 patients was 69 years. Forty-eight percent required dialysis and there was a 33% overall mortality. The mean age of patients in previous treatment studies has been between 50 and 55 years.
CONCLUSIONS: The greater severity of disease at presentation and poorer outcome than previously described is likely to be due to the high proportion of elderly patients. The incidence of vasculitis is increasing in the elderly but as this group has been poorly represented in clinical trials in renal vasculitis, applying the findings of these trials to their treatment may be hazardous. Future research should determine which treatments are safe and effective in the elderly. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331937     DOI: 10.1159/000079173

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  4 in total

1.  Clinical outcomes of ANCA-associated vasculitis in elderly patients.

Authors:  Ágnes Haris; Kálmán Polner; József Arányi; Henrik Braunitzer; Ilona Kaszás; István Mucsi
Journal:  Int Urol Nephrol       Date:  2014-04-23       Impact factor: 2.370

2.  A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity.

Authors:  Akio Koyama; Kunihiro Yamagata; Hirofumi Makino; Yoshihiro Arimura; Takashi Wada; Kosaku Nitta; Hiroshi Nihei; Eri Muso; Yoshio Taguma; Hidekazu Shigematsu; Hideto Sakai; Yasuhiko Tomino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-06-17       Impact factor: 2.801

3.  ANCA and IgA glomerulonephritis all in one: prognosis and complications.

Authors:  Pitchaphon Nissaisorakarn; Vivette D'Agati; Kisra Anis; Belinda Jim
Journal:  BMJ Case Rep       Date:  2017-10-09

4.  Simple, readily available clinical indices predict early and late mortality among patients with ANCA-associated vasculitis.

Authors:  Ágnes Haris; Kálmán Polner; József Arányi; Henrik Braunitzer; Ilona Kaszás; László Rosivall; Gábor Kökény; István Mucsi
Journal:  BMC Nephrol       Date:  2017-02-23       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.